Elos Medtech adjusts dividend policy and proposes no dividend for 2022
The board of directors of Elos Medtech AB has decided to update the company's dividend policy, in order to adapt the dividend to the company's large investment needs. The new dividend policy reads:Elos Medtech’s dividend policy stipulates that the dividend is to be based on the Group’s earnings performance, while taking into account its future development potential and financial position. The board's assessment is that any surplus funds in the coming years will need to be reinvested into the business, to cover the company's investment needs. In line with the new dividend policy, the